The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Annular Protofibrils Are a Structurally and Functionally Distinct Type of Amyloid Oligomer
Open accessAbstract
Amyloid oligomers are believed to play causal roles in several types of amyloid-related neurodegenerative diseases. Several different types of amyloid oligomers have been reported that differ in morphology, size, or toxicity, raising the question of the pathological significance and structural relationships between different amyloid oligomers. Annular protofibrils (APFs) have been described in oligomer preparations of many different amyloidogenic proteins and peptides as ring-shaped or pore-like structures. They are interesting because their pore-like morphology is consistent with numerous reports of membrane-permeabilizing activity of amyloid oligomers. Here we report the preparation of relatively homogeneous preparations of APFs and an antiserum selective for APFs (alphaAPF) compared with prefibrillar oligomers (PFOs) and fibrils. PFOs appear to be precursors for APF formation, which form in high yield after exposure to a hydrophobic-hydrophilic interface. Surprisingly, preformed APFs do not permeabilize lipid bilayers, unlike the precursor PFOs. APFs display a conformation-dependent, generic epitope that is distinct from that of PFOs and amyloid fibrils. Incubation of PFOs with phospholipids vesicles results in a loss of PFO immunoreactivity with a corresponding increase in alphaAPF immunoreactivity, suggesting that lipid vesicles catalyze the conversion of PFOs into APFs. The annular anti-protofibril antibody also recognizes heptameric alpha-hemolysin pores, but not monomers, suggesting that the antibody recognizes an epitope that is specific for a beta barrel structural motif.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434
Atomic structures of amyloid cross-β spines reveal varied steric zippers
Sawaya, M. R., Sambashivan, S., Nelson, R., Ivanova, M. I., Sievers, S. A., Apostol, M. I., Thompson, M. J., Balbirnie, M., Wiltzius, J. J. W., McFarlane, H. T., et al. (2007) · Nature · doi:10.1038/nature05695 · Cited by 2,271
Levine, H. (1993) · Protein Science · doi:10.1002/pro.5560020312 · Cited by 2,264
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.040 · Cited by 1,294
Amyloid pores from pathogenic mutations
Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., & Lansbury, P. T. (2002) · Nature · doi:10.1038/418291a · Cited by 1,289
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., & Teplow, D. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22364 · Cited by 1,145
Rationalization of the effects of mutations on peptide andprotein aggregation rates
Chiti, F., Stefani, M., Taddei, N., Ramponi, G., & Dobson, C. M. (2003) · Nature · doi:10.1038/nature01891 · Cited by 1,072
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014
Self-citationArispe, N., Rojas, E., & Pollard, H. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.567 · Cited by 926
Kayed, R., Sokolov, Y., Edmonds, B., McIntire, T. M., Milton, S. C., Hall, J. E., & Glabe, C. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400260200 · Cited by 902
Self-citationConway, K. A., Harper, J. D., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi991447r · Cited by 786
Kayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C. W., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J. L., et al. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-18 · Cited by 773
Self-citationThe Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease
Westerman, M. A., Cooper-Blacketer, D., Mariash, A., Kotilinek, L., Kawarabayashi, T., Younkin, L. H., Carlson, G. A., Younkin, S. G., & Ashe, K. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01858.2002 · Cited by 718
Observation of metastable Aβ amyloid protofibrils by atomic force microscopy
Harper, J. D., Wong, S. S., Lieber, C. M., & Lansbury, P. T. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90255-6 · Cited by 697
Janson, J., Ashley, R. H., Harrison, D., McIntyre, S., & Butler, P. C. (1999) · Diabetes · doi:10.2337/diabetes.48.3.491 · Cited by 612
Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease
Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90881-6 · Cited by 580
Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?
Lashuel, H. A., & Lansbury, P. T. (2006) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583506004422 · Cited by 400
Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis
Glabe, C. G., & Kayed, R. (2006) · Neurology · doi:10.1212/01.wnl.0000192103.24796.42 · Cited by 367
Self-citationOn the mechanism of membrane damage by Staphylococcus aureus alpha-toxin.
Füssle, R., Bhakdi, S., Sziegoleit, A., Tranum-Jensen, J., Kranz, T., & Wellensiek, H. J. (1981) · The Journal of cell biology · doi:10.1083/jcb.91.1.83 · Cited by 366
Ding, T. T., Lee, S.-J., Rochet, J.-C., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi020139h · Cited by 356
Structural and functional imaging with carbon nanotube AFM probes
Hafner, J. H., Cheung, C.-L., Woolley, A. T., & Lieber, C. M. (2001) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(01)00011-6 · Cited by 344
Conformational Abs recognizing a generic amyloid fibril epitope
O'Nuallain, B., & Wetzel, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022662599 · Cited by 333
Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice
Martins, I. C., Kuperstein, I., Wilkinson, H., Maes, E., Vanbrabant, M., Jonckheere, W., Van Gelder, P., Hartmann, D., D'Hooge, R., De Strooper, B., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601953 · Cited by 311
The Pathogenesis of Alzheimer Disease: An Alternative to the Amyloid Hypothesis
Terry, R. D. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199610000-00001 · Cited by 299
Anguiano, M., Nowak, R. J., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi020314u · Cited by 293
Shtilerman, M. D., Ding, T. T., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi0120906 · Cited by 281
A Common Fold Mediates Vertebrate Defense and Bacterial Attack
Rosado, C. J., Buckle, A. M., Law, R. H. P., Butcher, R. E., Kan, W.-T., Bird, C. H., Ung, K., Browne, K. A., Baran, K., Bashtannyk-Puhalovich, T. A., et al. (2007) · Science · doi:10.1126/science.1144706 · Cited by 278
Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregation.
Soreghan, B., Kosmoski, J., & Glabe, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61939-3 · Cited by 267
Self-citationPrefibrillar Amyloid Aggregates Could Be Generic Toxins in Higher Organisms
Baglioni, S., Casamenti, F., Bucciantini, M., Luheshi, L. M., Taddei, N., Chiti, F., Dobson, C. M., & Stefani, M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4809-05.2006 · Cited by 246
Structure of C8α-MACPF Reveals Mechanism of Membrane Attack in Complement Immune Defense
Hadders, M. A., Beringer, D. X., & Gros, P. (2007) · Science · doi:10.1126/science.1147103 · Cited by 240
Lashuel, H. A., Hartley, D. M., Petre, B. M., Wall, J. S., Simon, M. N., Walz, T., & Lansbury, P. T. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00927-6 · Cited by 237
Soluble Amyloid Oligomers Increase Bilayer Conductance by Altering Dielectric Structure
Sokolov, Y., Kozak, J. A., Kayed, R., Chanturiya, A., Glabe, C., & Hall, J. E. (2006) · The Journal of General Physiology · doi:10.1085/jgp.200609533 · Cited by 228
Self-citationAntibody-Mediated Resolution of Light Chain-Associated Amyloid Deposits
Hrncic, R., Wall, J., Wolfenbarger, D. A., Murphy, C. L., Schell, M., Weiss, D. T., & Solomon, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64639-1 · Cited by 213
Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm
Lal, R., Lin, H., & Quist, A. P. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.04.021 · Cited by 205
Soluble Amyloid Aβ-(1–40) Exists as a Stable Dimer at Low Concentrations
Garzon-Rodriguez, W., Sepulveda-Becerra, M., Milton, S., & Glabe, C. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21037 · Cited by 204
Self-citationKagan, B. L., Azimov, R., & Azimova, R. (2004) · Journal of Membrane Biology · doi:10.1007/s00232-004-0709-4 · Cited by 186
Protein Aggregation and Its Consequences for Human Disease
Dobson, C. (2006) · Protein & Peptide Letters · doi:10.2174/092986606775338362 · Cited by 176
Conformation‐Dependent Anti‐Amyloid Oligomer Antibodies
Kayed, R., & Glabe, C. G. (2006) · Methods in Enzymology · doi:10.1016/s0076-6879(06)13017-7 · Cited by 166
Self-citationGrammatopoulos, T. N., Jones, S. M., Ahmadi, F. A., Hoover, B. R., Snell, L. D., Skoch, J., Jhaveri, V. V., Poczobutt, A. M., Weyhenmeyer, J. A., & Zawada, W. M. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-1 · Cited by 165
β-Barrel membrane protein folding and structure viewed through the lens of α-hemolysin
Montoya, M., & Gouaux, E. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00663-6 · Cited by 140
Hardy, J. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330578 · Cited by 112
Pore-Forming Proteins Share Structural and Functional Homology with Amyloid Oligomers
Yoshiike, Y., Kayed, R., Milton, S. C. F., Takashima, A., & Glabe, C. G. (2007) · NeuroMolecular Medicine · doi:10.1007/s12017-007-0003-6 · Cited by 76
Self-citation(1999) · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
Cited by
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
Chiti, F., & Dobson, C. M. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045115 · Cited by 2,629
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651
Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044
Self-assembling peptide and protein amyloids: from structure to tailored function in nanotechnology
Wei, G., Su, Z., Reynolds, N. P., Arosio, P., Hamley, I. W., Gazit, E., & Mezzenga, R. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00542j · Cited by 904
Atomic-resolution structure of a disease-relevant Aβ(1–42) amyloid fibril
Wälti, M. A., Ravotti, F., Arai, H., Glabe, C. G., Wall, J. S., Böckmann, A., Güntert, P., Meier, B. H., & Riek, R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600749113 · Cited by 808
Self-citation
Metadata
- Authors
- Kayed, R., Pensalfini, A., Margol, L., Sokolov, Y., Sarsoza, F., Head, E., Hall, J., & Glabe, C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 284
- Issue
- 7
- Pages
- 4230-4237
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2011771839
- Cited by
- 348
- References
- 46
- FWCI
- 17.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.